Summary
Background
Pontine gliomas are the subgroup of brainstem gliomas with the worst prognosis. Controversial treatment approaches are discussed.
Patients and methods
Data of children with pontine gliomas treated in different prospective multi-center studies who were registered in the HIT-GBM database were pooled and analyzed addressing prognostic factors and the relevance of intensive treatment using contingency tables, Kaplan–Meier curves and Cox regression analyses.
Results
From 1983 to 2001, 153 patients (74 males, 79 females, mean age: 8.1 years) with pontine gliomas were registered. Twenty-one tumors were low-grade and 60 were high-grade gliomas (72 undefined histology: 67 no surgery, 5 incomplete data). Sixteen tumors were partially resected, and 125 were irradiated. Ninety children received chemotherapy according to the “HIT-GBM” protocols (“Hirntumor-Glioblastoma multiforme”). The one-year overall survival rate (1YOS) of all patients with pontine glioma was 39.9±4.3%. None of the surviving patients had an observation time longer than 3.9 years. Favorable prognostic factors seemed to be age younger than 4 years, low-grade histology and smaller tumor. All three major treatment modalities including resection, irradiation and chemotherapy had prognostic relevance in univariable analysis. Chemotherapy remained beneficial, even if the analysis was restricted to the subgroup of irradiated tumors (1YOS 45.8±5.4% vs. 34.4±13.5%, P=0.030).
Conclusion
Irradiation is an effective element for the treatment of pontine gliomas. Intensive chemotherapy seems to be important in achieving a better OS.
Similar content being viewed by others
References
Maria BL, Rehder K, Eskin TA, Hamed LM, Fennell EB, Quisling RG, Mickle JP, Marcus RB Jr, Drane WE, Mendenhall NP Brainstem glioma: I. Pathology, clinical features, and therapy J Child Neurol 8: 112–128, 1993
Fischbein NJ, Prados MD, Wara W, Russo C, Edwards MS, Barkovich AJ Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome Pediatr Neurosurg 24: 9–23, 1996
Fisher PG, Breiter SN, Carson BS, Wharam MD, Williams JA, Weingart JD, Foer DR, Goldthwaite PT, Tihan T, Burger PC A clinicopathologic reappraisal of brain stem tumor classification. Identification of pilocystic astrocytoma and fibrillary astrocytoma as distinct entities Cancer 89:1569–1576, 2000
Poussaint TY, Kowal JR, Barnes PD, Zurakowski D, Anthony DC, Goumnerova L, Tarbell NJ Tectal tumors of childhood: clinical and imaging follow-up Am J Neuroradiol 19: 977–983, 1998
May PL, Blaser SI, Hoffman HJ, Humphreys RP, Harwood-Nash DC Benign intrinsic tectal “tumors” in children J Neurosurg 74: 867–871, 1991
Farmer JP, Montes JL, Freeman CR, Meagher-Villemure K, Bond MC, O’Gorman AM Brainstem gliomas. A 10-year institutional review Pediatr Neurosurg 34: 206–214, 2001
Robertson PL, Muraszko KM, Brunberg JA, Axtell RA, Dauser RC, Turrisi AT Pediatric midbrain tumors: a benign subgroup of brainstem gliomas Pediatr Neurosurg 22: 65–73, 1995
Barkovich AJ, Krischer J, Kun LE, Packer R, Zimmerman RA, Freeman CR, Wara WM, Albright L, Allen JC, Hoffman HJ a classification system based on magnetic resonance imaging Pediatr Neurosurg 16: 73–83, 1990
Epstein F, Wisoff JH Intrinsic brainstem tumors in childhood: surgical indications J Neurooncol6: 309–317, 1988
Freeman CR, Farmer JP Pediatric brain stem gliomas: a review Int J Radiat Oncol Biol Phys40: 265–271, 1998
Walter AW, Gajjar A, Ochs JS, Langston JW, Sanford RA, Kun LE, Heideman R Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I/II study Med Pediatr Oncol 30: 28–33, 1998
Jenkin RD, Boesel C, Ertel I, Evans A, Hittle R, Ortega J, Sposto R, Wara W, Wilson C, Anderson J Brain-stem tumors in childhood: a prospective randomized trial of irradiation with and without adjuvant CCNU, VCR, and prednisone. A report of the Childrens Cancer Study Group J Neurosurg 66: 227–233, 1987
Wolff JE, Boos J, Kühl J HIT-GBM: multicenter study for children with malignant glioma Klin Paediatr 208: 193–196, 1996
Wolff JE, Molenkamp G, Westphal S, Pietsch T, Gnekow A, Kortmann RD, Kuehl J Oral trofosfamide and etoposide in pediatric patients with glioblastoma multiforme Cancer 89: 2131–2137, 2000
Wolff JE, Wagner S, Sindichakis M, Pietsch T, Gnekow A, Kortmann RD, Strater R, Kuehl J Simultaneous radiochemotherapy in pediatric patients with high-grade glioma: a phase I study Anticancer Res22: 3569–3572, 2002
Wolff JE, Westphal S, Molenkamp G, Gnekow A, Warmuth-Metz M, Rating D, Kuehl J Treatment of pediatric pontine glioma with oral trophosphamide and etoposide Br J Cancer 87: 945–949, 2002
Wagner S, Reinert C, Schmid HJ, Liebeskind AK, Jorch N, Langler A, Graf N, Warmuth-Metz M, Pietsch T, Peters O, Wolff JE High-dose Methotrexate prior to simultaneous radiochemotherapy in children with malignant high-grade gliomas Anticancer Res. 25: 2583–2588, 2005
Collett D: Strategy for model selection. In: Modelling Survival Data in Medical Research. Chapman and Hall, London, 1994, pp. 78–83
Jallo GI, Biser-Rohrbaugh A, Freed D Brainstem gliomas Childs Nerv Syst 20: 143–153, 2004
Burger PC Pathology of brain stem astrocytomas Pediatr Neurosurg 24: 35–40, 1996
Epstein FJ, Farmer JP Brain-stem glioma growth patterns J Neurosurg 78: 408–412, 1993
Packer RJ, Nicholson HS, Vezina LG, Johnson DL Brainstem gliomas Neurosurg Clin N Am 3: 863–879, 1992
Freeman CR, Bourgouin PM, Sanford RA, Cohen ME, Friedman HS, Kun LE Long term survivors of childhood brain stem gliomas treated with hyperfractionated radiotherapy. Clinical characteristics and treatment related toxicities. The Pediatric Oncology Group Cancer 77: 555–562, 1996
Packer RJ, Boyett JM, Zimmerman RA, Albright AL, Kaplan AM, Rorke LB, Selch MT, Cherlow JM, Finlay JL, Wara WM Outcome of children with brain stem gliomas after treatment with 7800 cGy of hyperfractionated radiotherapy. A Childrens Cancer Group Phase I/II Trial Cancer 74: 1827–1834, 1994
Lenard HG, Engelbrecht V, Janssen G, Wechsler W, Tautz C Complete remission of a diffuse pontine glioma Neuropediatrics 29: 328–330, 1998
Vandertop WP, Hoffman HJ, Drake JM, Humphreys RP, Rutka JT, Amstrong DC, Becker L Focal midbrain tumors in children Neurosurgery 31: 186–194, 1992
Edwards MS, Wara WM, Ciricillo SF, Barkovich AJ Focal brain-stem astrocytomas causing symptoms of involvement of the facial nerve nucleus: long-term survival in six pediatric cases J Neurosurg 80: 20–25, 1994
Kaplan AM, Albright AL, Zimmerman RA, Rorke LB, Li H, Boyett JM, Finlay JL, Wara WM, Packer RJ Brainstem gliomas in children. A Children’s Cancer Group review of 119 cases Pediatr Neurosurg 24: 185–192, 1996
Lesniak MS, Klem JM, Weingart J, Carson BS Surgical outcome following resection of contrast-enhanced pediatric brainstem gliomas Pediatr Neurosurg 39: 314–322, 2003
Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children’s Cancer Group Neurosurgery 33: 1026–1029, 1993
Shrieve DC, Wara WM, Edwards MS, Sneed PK, Prados MD, Cogen PH, Larson DA, Levin VA Hyperfractionated radiation therapy for gliomas of the brainstem in children and in adults Int J Radiat Oncol Biol Phys. 24: 599–610, 1992
Prados MD, Wara WM, Edwards MS, Larson DA, Lamborn K, Levin VA The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy Int J Radiat Oncol Biol Phys. 32: 85–91, 1995
Mandell LR, Kadota R, Freeman C, Douglass EC, Fontanesi J, Cohen ME, Kovnar E, Burger P, Sanford RA, Kepner J, Friedman H, Kun LE There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group phase III trial comparing conventional vs. hyperfractionated radiotherapy. Int J Radiat Oncol Biol Phys 43: 959–964, 1999
Freeman CR, Kepner J, Kun LE, Sanford RA, Kadota R, Mandell L, Friedman H A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? Int J Radiat Oncol Biol Phys. 47: 561–564, 2000
Benesch M, Lackner H, Moser A, Kerbl R, Schwinger W, Oberbauer R, Eder HG, Mayer R, Wiegele K, Urban C Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas Pediatr Neurosurg 35: 173–180, 2001
Acknowledgements
We thank the participants of the various studies for submitting the data and Norman Jaffe for helpful discussions and correcting the manuscript. Supported by the Deutsche Kinderkrebsstiftung, Germany.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wagner, S., Warmuth-Metz, M., Emser, A. et al. Treatment options in childhood pontine gliomas. J Neurooncol 79, 281–287 (2006). https://doi.org/10.1007/s11060-006-9133-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-006-9133-1